(Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B | 8.47%174.61B | 6.15%111.71B | 10.27%56.9B | 12.46%215.82B | 14.72%160.97B | 20.73%105.24B |
Operating income | 13.11%197.51B | 18.70%132.59B | 16.39%66.23B | 7.49%231.98B | 8.47%174.61B | 6.15%111.71B | 10.27%56.9B | 12.46%215.82B | 14.72%160.97B | 20.73%105.24B |
Operating expenses | -14.22%-173.55B | -19.50%-115.53B | -16.19%-57.59B | -7.59%-201.49B | -9.10%-151.93B | -5.98%-96.68B | -11.02%-49.57B | -13.38%-187.28B | -15.90%-139.26B | -23.19%-91.23B |
Gross profit | 5.67%23.96B | 13.51%17.06B | 17.80%8.63B | 6.81%30.49B | 4.45%22.68B | 7.26%15.03B | 5.41%7.33B | 6.79%28.54B | 7.65%21.71B | 6.88%14.01B |
Selling expenses | -1.29%-10.47B | -13.81%-7.73B | -18.05%-3.91B | -7.22%-14.28B | -1.18%-10.34B | -7.42%-6.79B | -4.23%-3.31B | -9.53%-13.32B | -9.56%-10.22B | -3.34%-6.32B |
Administrative expenses | -11.62%-4.19B | -19.00%-2.76B | -15.70%-1.38B | 2.95%-4.99B | -5.09%-3.76B | 0.03%-2.32B | 2.57%-1.19B | -8.70%-5.14B | -2.13%-3.57B | -4.38%-2.32B |
Research and development expenses | -5.70%-1.47B | -26.76%-1.03B | -20.82%-540.69M | -6.29%-2.11B | -1.63%-1.39B | 7.99%-809.67M | -7.95%-447.5M | -19.96%-1.99B | -31.38%-1.37B | -30.04%-880.03M |
Profit from asset sales | -92.67%104.58M | -94.83%73.75M | 188.72%21.78M | 2,368.58%1.44B | 22,234.19%1.43B | 23,988.34%1.43B | 7,912.76%7.54M | 11.77%58.29M | 463.86%6.39M | 587.44%5.92M |
Revaluation surplus | 225.04%239.02M | 675.23%196.84M | 240.65%89.4M | 206.18%218.74M | 141.65%73.54M | 171.34%25.39M | 47.56%-63.56M | -276.38%-206M | -259.61%-176.57M | -134.42%-35.59M |
-Changes in the fair value of other assets | 225.04%239.02M | 675.23%196.84M | 240.65%89.4M | 206.18%218.74M | 141.65%73.54M | 171.34%25.39M | 47.56%-63.56M | -276.38%-206M | -259.61%-176.57M | -134.42%-35.59M |
Impairment and provision | -15.91%-262.6M | -51.60%-270.22M | -362.28%-169.87M | -360.73%-643.93M | 13.13%-226.55M | 3.90%-178.24M | 60.88%-36.75M | 83.73%-139.76M | 55.24%-260.79M | 51.88%-185.47M |
-Other impairment is provision | -15.91%-262.6M | -51.60%-270.22M | -362.28%-169.87M | -360.73%-643.93M | 13.13%-226.55M | 3.90%-178.24M | 60.88%-36.75M | 83.73%-139.76M | 55.24%-260.79M | 51.88%-185.47M |
Special items of operating profit | -49.72%346.45M | -61.50%171.36M | 41.47%356.49M | -59.88%926.88M | -67.03%689.04M | -76.12%445.11M | -83.73%251.99M | 51.48%2.31B | 100.01%2.09B | 145.15%1.86B |
Operating profit | -10.54%7.71B | -17.32%5.33B | 23.59%2.91B | 9.28%10.33B | 11.48%8.62B | 11.00%6.45B | -28.85%2.35B | 12.19%9.45B | 19.74%7.73B | 34.97%5.81B |
Financing cost | -15.71%-1.15B | -19.16%-773.22M | -16.64%-418.18M | -5.45%-1.31B | -7.26%-997.59M | -12.10%-648.91M | -13.43%-358.53M | -0.47%-1.25B | 5.04%-930.05M | 13.67%-578.87M |
Special items of earning before tax | 30.84%-36.96M | 41.10%-24.29M | 115.24%1.3M | -234.51%-206.3M | -1,031.28%-53.44M | -228.25%-41.24M | -261.75%-8.55M | -592.50%-61.67M | -102.95%-4.72M | 57.60%-12.56M |
Earning before tax | -13.86%6.52B | -21.26%4.53B | 25.44%2.49B | 8.16%8.81B | 11.35%7.57B | 10.36%5.76B | -33.72%1.99B | 13.50%8.14B | 24.13%6.8B | 44.78%5.22B |
Tax | 1.16%-1.57B | 6.45%-1.12B | -18.63%-538.85M | 2.83%-1.82B | -10.54%-1.58B | -13.39%-1.19B | 26.63%-454.25M | -19.04%-1.87B | -28.20%-1.43B | -45.67%-1.05B |
After-tax profit from continuing operations | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B | 11.56%5.98B | 9.59%4.56B | -35.56%1.53B | 11.94%6.27B | 23.09%5.36B | 44.55%4.16B |
Earning after tax | -17.22%4.95B | -25.14%3.42B | 27.46%1.95B | 11.43%6.99B | 11.56%5.98B | 9.59%4.56B | -35.56%1.53B | 11.94%6.27B | 23.09%5.36B | 44.55%4.16B |
Minority profit | -1.14%1.16B | -7.07%807.18M | 54.77%435.4M | 16.41%1.37B | 33.04%1.17B | 45.49%868.61M | 9.10%281.31M | 6.50%1.18B | 16.39%879.72M | 36.21%597.03M |
Profit attributable to shareholders | -21.13%3.8B | -29.38%2.61B | 21.31%1.52B | 10.28%5.62B | 7.35%4.81B | 3.58%3.7B | -40.99%1.25B | 13.28%5.09B | 24.49%4.48B | 46.05%3.57B |
Basic earnings per share | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 | -8.23%1.45 | -10.32%1.13 | -41.33%0.44 | 13.29%1.79 | 24.41%1.58 | 46.51%1.26 |
Diluted earnings per share | -28.97%1.03 | -37.17%0.71 | -6.82%0.41 | -10.06%1.61 | -8.23%1.45 | -10.32%1.13 | -41.33%0.44 | 13.29%1.79 | 24.41%1.58 | 46.51%1.26 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data